Copyright
©The Author(s) 2023.
World J Gastroenterol. Jul 21, 2023; 29(27): 4289-4316
Published online Jul 21, 2023. doi: 10.3748/wjg.v29.i27.4289
Published online Jul 21, 2023. doi: 10.3748/wjg.v29.i27.4289
0 min | 5 min | 15 min | 60 min |
Relative volume (healthy/perforation, %) of the brain, heart, azygos vein, inferior caval vein, superior mesenteric vein, and abdominal aorta in rats immediately after perforation | Application of the 1 mL/rat through the perforated defect in the injured stomach at 5 min following perforation | Relative volume (healthy/perforation, healthy/perforation + therapy, %) of the brain, inferior caval vein, and superior mesenteric vein, and relative volume (control/treated, %) of the heart, azygos vein, in rats at 15 min and 60 min following stomach perforation | |
Relative volume (healthy/perforation) (%) of the brain, mean ± SD | Medication | Relative volume (healthy/perforation + therapy, %) of the brain, mean ± SD | |
116 ± 3a | Saline 5 mL/kg (control) | 124 ± 2a,b | 124 ± 2a,b |
120 ± 2a | BPC 157 10 μg/kg | 100 ± 1b,c | 99 ± 2b,c |
121 ± 2a | BPC 157 10 ng/kg | 101 ± 3b,c | 100 ± 1b,c |
- | Relative volume (control/treated, %) of the heart, mean ± SD | ||
BPC 157 10 μg/kg | 137 ± 4c | 141 ± 5c | |
BPC 157 10 ng/kg | 136 ± 3c | 138 ± 4c | |
Relative volume (control/treated, %) of the azygos vein, mean ± SD | |||
BPC 157 10 μg/kg | 66 ± 6c | 58 ± 7c | |
BPC 157 10 ng/kg | 64 ± 4c | 54 ± 8c | |
Relative volume (healthy/perforation + therapy, %) of the inferior caval vein, mean ± SD | |||
130 ± 3a | Saline 5 mL/kg (control) | 164 ± 8a,b | 174 ± 9a,b |
128 ± 4a | BPC 157 10 μg/kg | 98 ± 2b,c | 100 ± 2b,c |
126 ± 4a | BPC 157 10 ng/kg | 100 ± 3b,c | 99 ± 1b,c |
Relative volume (healthy/perforation + therapy, %) of the superior mesenteric vein, mean ± SD | |||
180 ± 5a | Saline 5 mL/kg (control) | 204 ± 8a,b | 212 ± 9a,b |
188 ± 9a | BPC 157 10 μg/kg | 96 ± 6b,c | 99 ± 7b,c |
186 ± 8a | BPC 157 10 ng/kg | 98 ± 6b,c | 101 ± 1b,c |
- Citation: Kalogjera L, Krezic I, Smoday IM, Vranes H, Zizek H, Yago H, Oroz K, Vukovic V, Kavelj I, Novosel L, Zubcic S, Barisic I, Beketic Oreskovic L, Strbe S, Sever M, Sjekavica I, Skrtic A, Boban Blagaic A, Seiwerth S, Sikiric P. Stomach perforation-induced general occlusion/occlusion-like syndrome and stable gastric pentadecapeptide BPC 157 therapy effect. World J Gastroenterol 2023; 29(27): 4289-4316
- URL: https://www.wjgnet.com/1007-9327/full/v29/i27/4289.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i27.4289